Michael Pham, M.D., M.P.H.

Cardiologist

Heart Transplant Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-5468
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Board Certification: Advanced Heart Failure and Transplant Cardiology, American Board of Internal Medicine

Internship: UCSF Medical Center (1999) CA

Medical Education: UCSF Medical Center (1998) CA

Residency: UCSF Medical Center (2001) CA

Fellowship: Stanford University School of Medicine (2002) CA

Board Certification: Cardiovascular Disease, American Board of Internal Medicine (2004)

Administrative Appointments

Associate Medical Director, Heart Transplant Program, Stanford Hospital and Clinics, 2011

UNOS Primary Heart Transplant Physician, Stanford Hospital and Clinics, 2011

Medical Director, Advanced Heart Failure and Transplantation, VA Palo Alto Health Care System, 2005

Chair, Heart Transplant Quality Council, Stanford Hospital and Clinics, 2010

Co-Chair, Solid Organ Transplant Quality Council, Stanford Hospital and Clinics, 2011

Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients.
Deng, M. C., Elashoff, B., Pham, M. X., Teuteberg, J. J., Kfoury, A. G., & Valantine, H. A. (2014). Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients. Transplantation, 97(6), 708-714.

B-Type Natriuretic Peptide Predicts 30-Day Readmission for Heart Failure but not Readmission for Other Causes.
Flint, K. M., Allen, L. A., Pham, M., & Heidenreich, P. A. (2014). B-Type Natriuretic Peptide Predicts 30-Day Readmission for Heart Failure but not Readmission for Other Causes. Journal of the American Heart Association, 3(3).

Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.
Vrtovec, B., Haddad, F., Pham, M., Deuse, T., Fearon, W. F., & Hunt, S. A. (2013). Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients. Transplantation proceedings, 45(6), 2406-2409.

Forecasting the impact of heart failure in the United States: a policy statement from the american heart association.
Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., & Trogdon, J. G. (2013). Forecasting the impact of heart failure in the United States: a policy statement from the american heart association. Circulation. Heart failure, 6(3), 606-619.

Clinical and Echocardiographic Presentation of Rejection Episodes Following Heart Transplantation
Sudini, N. L., Huo, J., Pan, S., Montoya, J., Leon, S., & Haddad, F. (2013). Clinical and Echocardiographic Presentation of Rejection Episodes Following Heart Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 32(4), S254-S254.

Divergent Trends in Survival and Readmission Following a Hospitalization for Heart Failure in the Veterans Affairs Health Care System 2002 to 2006
Heidenreich, P. A., Sahay, A., Kapoor, J. R., Pham, M. X., & Massie, B. (2010). Divergent Trends in Survival and Readmission Following a Hospitalization for Heart Failure in the Veterans Affairs Health Care System 2002 to 2006. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56(5), 362-368.

Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation
Pham, M. X., Teuteberg, J. J., Kfoury, A. G., Starling, R. C., Deng, M. C., & Valantine, H. A. (2010). Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation. NEW ENGLAND JOURNAL OF MEDICINE, 362(20), 1890-1900.

Changing trends in infectious disease in heart transplantation
Haddad, F., Deuse, T., Pham, M., Khazanie, P., Rosso, F., & Montoya, J. G. (2010). Changing trends in infectious disease in heart transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 29(3), 306-315.

Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection
Haddad, F., Fisher, P., Pham, M., Berry, G., Weisshaar, D., & Hunt, S. (2009). Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodynamically Compromising Rejection. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(4), 312-319.

Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation
Khazanie, P., Haddad, F., Simos, A. M., Pham, M., Weisshaar, D. M., & Fearon, W. (2009). Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 53(10), A182-A182.

Microvascular Drysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation
Khazanie, P., Haddad, F., Simos, A. M., Weissbaar, D. M., Desai, S. V., & Fearon, W. (2009). Microvascular Drysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(2), S228-S228.

Changing Trends in Infectious Complications among Heart Transplant Recipients
Haddad, F., Deuse, T., Rosso, P., Pham, M., Khazanie, P., & Montoya, J. G. (2009). Changing Trends in Infectious Complications among Heart Transplant Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 28(2), S237-S238.

Twenty-year survivors of heart transplantation at Stanford University
Deuse, T., Haddad, F., Pham, M., Hunt, S., Valantine, H., & Reitz, B. A. (2008). Twenty-year survivors of heart transplantation at Stanford University. AMERICAN JOURNAL OF TRANSPLANTATION, 8(9), 1769-1774.

Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation
Sinha, S. S., Pham, M. X., Vagelos, R. H., Perlroth, M. G., Hunt, S. A., & Fearon, W. F. (2008). Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. AMERICAN HEART JOURNAL, 155(5).

Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial
Pham, M. X., Deng, M. C., Kfoury, A. G., Teuteberg, J. J., Starling, R. C., & Valantine, H. (2007). Molecular testing for long-term rejection surveillance in heart transplant recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26(8), 808-814.

Molecular testing in the management of cardiac transplant recipients: Initial clinical experience
Starling, R. C., Pham, M., Valantine, H., Miller, L., Eisen, H., & Deng, M. C. (2006). Molecular testing in the management of cardiac transplant recipients: Initial clinical experience. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 25(12), 1389-1395.

Rapamycin therapy improves coronary physiology after cardiac transplantation
Sinha, S. S., Lee, D. P., Pham, M. X., Vagelos, R. H., Hunt, S. A., & Fearon, W. F. (2006). Rapamycin therapy improves coronary physiology after cardiac transplantation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 47(4), 51A-51A.

Prognostic value electrocardiographic criteria for left ventricular hypertrophy
Hsieh, B. P., Pham, M. X., & Froelicher, V. F. (2005). Prognostic value electrocardiographic criteria for left ventricular hypertrophy. AMERICAN HEART JOURNAL, 150(1), 161-167.

Prognostic value of low-level cardiac troponin-1 elevations in patients without definite acute coronary syndromes
Pham, M. X., Whooley, M. A., Evans, G. T., Liu, C., Emadi, H., & Fleischmann, K. E. (2004). Prognostic value of low-level cardiac troponin-1 elevations in patients without definite acute coronary syndromes. AMERICAN HEART JOURNAL, 148(5), 776-782.

Cardiac xenotransplantation
Pham, M. X., Hunt, S. A., & Johnson, F. L. (2004). Cardiac xenotransplantation. CORONARY ARTERY DISEASE, 15(2), 99-105.